BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 9351826)

  • 21. Evidence for the involvement of two pathways in activation of extracellular signal-regulated kinase (Erk) and cell proliferation by Gi and Gq protein-coupled receptors in osteoblast-like cells.
    Caverzasio J; Palmer G; Suzuki A; Bonjour JP
    J Bone Miner Res; 2000 Sep; 15(9):1697-706. PubMed ID: 10976990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation.
    Welham MJ; Duronio V; Leslie KB; Bowtell D; Schrader JW
    J Biol Chem; 1994 Aug; 269(33):21165-76. PubMed ID: 8063737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts.
    Haugh JM; Huang AC; Wiley HS; Wells A; Lauffenburger DA
    J Biol Chem; 1999 Nov; 274(48):34350-60. PubMed ID: 10567412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shc associates with an unphosphorylated form of the p21ras guanine nucleotide exchange factor mSOS.
    de Vries-Smits AM; Pronk GJ; Medema JP; Burgering BM; Bos JL
    Oncogene; 1995 Mar; 10(5):919-25. PubMed ID: 7898933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G protein beta gamma subunits stimulate phosphorylation of Shc adapter protein.
    Touhara K; Hawes BE; van Biesen T; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9284-7. PubMed ID: 7568118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor.
    Chen Y; Grall D; Salcini AE; Pelicci PG; Pouysségur J; Van Obberghen-Schilling E
    EMBO J; 1996 Mar; 15(5):1037-44. PubMed ID: 8605873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
    Thirone AC; Carvalho CR; Saad MJ
    Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localizing a control region in the pathway to leukotriene C(4) secretion following stimulation of human basophils with anti-IgE antibody.
    Miura K; Lavens-Phillips S; MacGlashan DW
    J Immunol; 2001 Dec; 167(12):7027-37. PubMed ID: 11739523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The critical role of c-Src and the Shc/Grb2/ERK2 signaling pathway in angiotensin II-dependent VSMC proliferation.
    Sayeski PP; Ali MS
    Exp Cell Res; 2003 Jul; 287(2):339-49. PubMed ID: 12837289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
    Smit L; van der Horst G; Borst J
    Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors.
    Smit L; van der Horst G; Borst J
    J Biol Chem; 1996 Apr; 271(15):8564-9. PubMed ID: 8621483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites.
    Sasaoka T; Langlois WJ; Bai F; Rose DW; Leitner JW; Decker SJ; Saltiel A; Gill GN; Kobayashi M; Draznin B; Olefsky JM
    J Biol Chem; 1996 Apr; 271(14):8338-44. PubMed ID: 8626530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular targets of CD45 in B cell antigen receptor signal transduction.
    Pao LI; Bedzyk WD; Persin C; Cambier JC
    J Immunol; 1997 Feb; 158(3):1116-24. PubMed ID: 9013950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases.
    Honma M; Higuchi O; Shirakata M; Yasuda T; Shibuya H; Iemura S; Natsume T; Yamanashi Y
    Genes Cells; 2006 Feb; 11(2):143-51. PubMed ID: 16436051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation.
    Mainiero F; Murgia C; Wary KK; Curatola AM; Pepe A; Blumemberg M; Westwick JK; Der CJ; Giancotti FG
    EMBO J; 1997 May; 16(9):2365-75. PubMed ID: 9171350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
    Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH
    EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling.
    Mood K; Saucier C; Ishimura A; Bong YS; Lee HS; Park M; Daar IO
    J Cell Physiol; 2006 Apr; 207(1):271-85. PubMed ID: 16331688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flt3 ligand induces tyrosine phosphorylation of gab1 and gab2 and their association with shp-2, grb2, and PI3 kinase.
    Zhang S; Broxmeyer HE
    Biochem Biophys Res Commun; 2000 Oct; 277(1):195-9. PubMed ID: 11027663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p21Ras activation by the guanine nucleotide exchange factor Sos, requires the Sos/Grb2 interaction and a second ligand-dependent signal involving the Sos N-terminus.
    Byrne JL; Paterson HF; Marshall CJ
    Oncogene; 1996 Nov; 13(10):2055-65. PubMed ID: 8950972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of mitogenic effect of fluoride on fetal rat osteoblastic cells: evidence for Shc, Grb2 and P-CREB-dependent pathways.
    Chae HJ; Chae SW; Kang JS; Kim DE; Kim HR
    Res Commun Mol Pathol Pharmacol; 1999; 105(3):185-99. PubMed ID: 10954125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.